Development and Technical Validation of an Immunoassay for the Detection of APP669−711 (Aβ−3−40) in Biological Samples

Autor: Klafki, Hans W., Rieper, Petra, Matzen, Anja, Zampar, Silvia, Wirths, Oliver, Vogelgsang, Jonathan, Osterloh, Dirk, Rohdenburg, Lara, Oberstein, Timo J., Jahn, Olaf, Beyer, Isaak, Lachmann, Ingolf, Knölker, Hans-Joachim, Wiltfang, Jens

Publikováno v: International Journal of Molecular Sciences
International journal of molecular sciences 21(18), 6564-(2020). doi:10.3390/ijms21186564
International Journal of Molecular Sciences, Vol 21, Iss 6564, p 6564 (2020)
Volume 21
Issue 18

The ratio of amyloid precursor protein (APP)669&ndash
711 (A&beta
&minus
3&ndash
40)/A&beta
1&ndash
42 in blood plasma was reported to represent a novel Alzheimer&rsquo
s disease biomarker. Here, we describe the cha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::49539aea70a4b91596661a9bcf26fa10
https://opus4.kobv.de/opus4-fau/files/20433/ijms-21-06564-v2.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.

Autor: Lewczuk, Piotr, Matzen, Anja, Blennow, Kaj, Parnetti, Lucilla, Molinuevo, Jose Luis, Eusebi, Paolo, Kornhuber, Johannes, Morris, John C., Fagan, Anne M.

Publikováno v: Journal of Alzheimer's Disease; 2017, Vol. 55 Issue 2, p813-822, 10p

Development and Technical Validation of an Immunoassay for the Detection of APP669–711 (Aβ−3–40) in Biological Samples.

Autor: Klafki, Hans W., Rieper, Petra, Matzen, Anja, Zampar, Silvia, Wirths, Oliver, Vogelgsang, Jonathan, Osterloh, Dirk, Rohdenburg, Lara, Oberstein, Timo J., Jahn, Olaf, Beyer, Isaak, Lachmann, Ingolf, Knölker, Hans-Joachim, Wiltfang, Jens

Publikováno v: International Journal of Molecular Sciences; Sep2020, Vol. 21 Issue 18, p6564-6564, 1p